-
1
-
-
57349138291
-
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients
-
Jamerson K, Weber MA, Bakris GL, et al. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med. 2008; 359: 2417-2428.
-
(2008)
N Engl J Med
, vol.359
, pp. 2417-2428
-
-
Jamerson, K.1
Weber, M.A.2
Bakris, G.L.3
-
2
-
-
0038460302
-
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 Report
-
DOI 10.1001/jama.289.19.2560
-
Chobanian AV, Bakris GL, Black HR, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003; 289: 2560-2572. (Pubitemid 37430158)
-
(2003)
Journal of the American Medical Association
, vol.289
, Issue.19
, pp. 2560-2572
-
-
Chobanian, A.V.1
Bakris, G.L.2
Black, H.R.3
Cushman, W.C.4
Green, L.A.5
Izzo Jr., J.L.6
Jones, D.W.7
Materson, B.J.8
Oparil, S.9
Wright Jr., J.T.10
Roccella, E.J.11
-
3
-
-
1642326305
-
Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines
-
See comment.
-
Cifkova R, Erdine S, Fagard R, et al. Practice guidelines for primary care physicians: 2003 ESH/ESC hypertension guidelines. [See comment]. J Hypertens. 2003; 21: 1779-1786.
-
(2003)
J Hypertens
, vol.21
, pp. 1779-1786
-
-
Cifkova, R.1
Erdine, S.2
Fagard, R.3
-
4
-
-
34249655660
-
Treatment of hypertension in the prevention and management of ischemic heart disease: A scientific statement from the American Heart Association council for high blood pressure research and the councils on clinical cardiology and epidemiology and prevention
-
DOI 10.1161/CIRCULATIONAHA.107.183885
-
Rosendorff C, Black HR, Cannon CP, et al. Treatment of hypertension in the prevention and management of ischemic heart disease: a scientific statement from the American Heart Association Council for High Blood Pressure Research and the Councils on Clinical Cardiology and Epidemiology and Prevention. Circulation. 2007; 115: 2761-2788. (Pubitemid 46842793)
-
(2007)
Circulation
, vol.115
, Issue.21
, pp. 2761-2788
-
-
Rosendorff, C.1
Black, H.R.2
Cannon, C.P.3
Gersh, B.J.4
Gore, J.5
Izzo Jr., J.L.6
Kaplan, N.M.7
O'Connor, C.M.8
O'Gara, P.T.9
Oparil, S.10
-
5
-
-
0037079309
-
Age-specific relevance of usual blood pressure to vascular mortality: A meta-analysis of individual data for one million adults in 61 prospective studies
-
DOI 10.1016/S0140-6736(02)11911-8
-
Lewington S, Clarke R, Qizilbash N, et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002; 360: 1903-1913. (Pubitemid 35472129)
-
(2002)
Lancet
, vol.360
, Issue.9349
, pp. 1903-1913
-
-
Lewington, S.1
Clarke, R.2
Qizilbash, N.3
Peto, R.4
Collins, R.5
-
6
-
-
0032513878
-
Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: Principal results of the Hypertension Optimal Treatment (HOT) randomised trial
-
DOI 10.1016/S0140-6736(98)04311-6
-
Hansson L, Zanchetti A, Carruthers SG, et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomized trial. Lancet. 1998; 351: 1755-1762. (Pubitemid 28269185)
-
(1998)
Lancet
, vol.351
, Issue.9118
, pp. 1755-1762
-
-
Hansson, L.1
Zanchetti, A.2
Carruthers, S.G.3
Dahlof, B.4
Elmfeldt, D.5
Julius, S.6
Menard, J.7
Rahn, K.H.8
Wedel, H.9
Westerling, S.10
-
7
-
-
0037145856
-
Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: Results from the AASK trial
-
DOI 10.1001/jama.288.19.2421
-
Wright JT, Jr., Bakris G, Greene T, et al. Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA. 2002; 288: 2421-2431. (Pubitemid 35340538)
-
(2002)
Journal of the American Medical Association
, vol.288
, Issue.19
, pp. 2421-2431
-
-
Wright Jr., J.T.1
Bakris, G.2
Greene, T.3
Agodoa, L.Y.4
Appel, L.J.5
Charleston, J.6
Cheek, D.7
Douglas-Baltimore, J.G.8
Gassman, J.9
Glassock, R.10
Hebert, L.11
Jamerson, K.12
Lewis, J.13
Phillips, R.A.14
Toto, R.D.15
Middleton, J.P.16
Rostand, S.G.17
-
8
-
-
7744231805
-
Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure. the CAMELOT study: A randomized controlled trial
-
DOI 10.1001/jama.292.18.2217
-
Nissen SE, Tuzcu EM, Libby P, et al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004; 292: 2217-2225. (Pubitemid 39473159)
-
(2004)
Journal of the American Medical Association
, vol.292
, Issue.18
, pp. 2217-2226
-
-
Nissen, S.E.1
Tuzcu, E.M.2
Libby, P.3
Thompson, P.D.4
Ghali, M.5
Garza, D.6
Berman, L.7
Shi, H.8
Buebendorf, E.9
Topol, E.J.10
-
9
-
-
33646829274
-
Lower target blood pressures are safe and effective for the prevention of recurrent stroke: The PROGRESS trial
-
DOI 10.1097/01.hjh.0000226212.34055.86, PII 0000487220060600000031
-
Arima H, Chalmers J, Woodward M, et al. Lower target blood pressures are safe and effective for the prevention of recurrent stroke: the PROGRESS trial. J Hypertens. 2006; 24: 1201-1208. (Pubitemid 43772329)
-
(2006)
Journal of Hypertension
, vol.24
, Issue.6
, pp. 1201-1208
-
-
Arima, H.1
Chalmers, J.2
Woodward, M.3
Anderson, C.4
Rodgers, A.5
Davis, S.6
MacMahon, S.7
Neal, B.8
-
11
-
-
0242654867
-
Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively-designed overviews of randomised trials
-
DOI 10.1016/S0140-6736(03)14739-3
-
Turnbull F, Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet. 2003; 362: 1527-1535. (Pubitemid 37410190)
-
(2003)
Lancet
, vol.362
, Issue.9395
, pp. 1527-1535
-
-
Turnbull, F.1
-
12
-
-
0344373794
-
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
-
ALLHAT Officers, Coordinators for the ALLHAT Collaborative Research Group.
-
ALLHAT Officers, Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA. 2002; 288: 2981-2997.
-
(2002)
JAMA
, vol.288
, pp. 2981-2997
-
-
-
13
-
-
0343487983
-
Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension
-
The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.
-
Staessen JA, Fagard R, Thijs L, et al. Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Lancet. 1997; 350: 757-764.
-
(1997)
Lancet
, vol.350
, pp. 757-764
-
-
Staessen, J.A.1
Fagard, R.2
Thijs, L.3
-
14
-
-
0025831464
-
Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: Final results of the systolic hypertension in the elderly program (SHEP)
-
SHEP-Cooperative-Research-Group.
-
SHEP-Cooperative-Research-Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the systolic hypertension in the elderly program (SHEP). JAMA. 1991; 265: 3255-3264.
-
(1991)
JAMA.
, vol.265
, pp. 3255-3264
-
-
|